Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

This press release does not constitute an offer to sell or the solicitation of an offer to buy the securities, nor shall ...

Pacira's Stock is Down 76% Over the Last Decade, While the Board and Management Have Enriched Themselves at a Cost of Half a Billion Dollars, Roughly 50% of the Current Market Cap Under CEO and Board ...

For years, I practised medicine with cool certainty, comfortable with life-and-death decisions. Then, one day, I couldn’t ...

The Fund’s largest detractors from performance in the fourth quarter included Jazz Pharmaceuticals, Boyd Gaming, Park Hotels ...

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, has entered into privately negotiated exchange and ...

Form Formal Sovereignty to Substantive Sovereignty. Canada • March 11, 2025 • Sam Gindin. The danger confronting Canadians is ...

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...

UVA School of Medicine emeritus professor Dr. Frederick G. Hayden helped design the trial and presented the results Wednesday ...

Dogs are better than people on so many levels. These are our top reasons why dogs are better than people Whether it’s their ...